245 related articles for article (PubMed ID: 8160192)
21. Poly(ADP-ribosyl)ation, PARP, and aging.
Beneke S; Bürkle A
Sci Aging Knowledge Environ; 2004 Dec; 2004(49):re9. PubMed ID: 15590998
[TBL] [Abstract][Full Text] [Related]
22. Physiology and pathophysiology of poly(ADP-ribosyl)ation.
Bürkle A
Bioessays; 2001 Sep; 23(9):795-806. PubMed ID: 11536292
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-induced cell death and poly[adenosine diphosphate(ADP)-ribosyl]ation: increased toxicity of dexamethasone on mouse S49.1 lymphoma cells with the poly(ADP-ribosyl)ation inhibitor benzamide.
Wielckens K; Delfs T
Endocrinology; 1986 Nov; 119(5):2383-92. PubMed ID: 2429833
[TBL] [Abstract][Full Text] [Related]
24. Effect of poly(ADP-ribosyl)ation inhibitors on the genotoxic effects of the boron neutron capture reaction.
Oliveira NG; Castro M; Rodrigues AS; Gonçalves IC; Martins C; Toscano Rico JM; Rueff J
Mutat Res; 2005 May; 583(1):36-48. PubMed ID: 15866464
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis.
Yoon YS; Kim JW; Kang KW; Kim YS; Choi KH; Joe CO
J Biol Chem; 1996 Apr; 271(15):9129-34. PubMed ID: 8621564
[TBL] [Abstract][Full Text] [Related]
26. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
[TBL] [Abstract][Full Text] [Related]
27. Age-dependent increase of DNA topoisomerase II activity in quail oviduct; modulation of the nuclear matrix-associated enzyme activity by protein phosphorylation and poly(ADP-ribosyl)ation.
Schröder HC; Steffen R; Wenger R; Ugarković D; Müller WE
Mutat Res; 1989; 219(5-6):283-94. PubMed ID: 2559326
[TBL] [Abstract][Full Text] [Related]
28. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
29. Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.
Qian H; Xu J; Lalioti MD; Gulle K; Sakkas D
Biol Reprod; 2010 May; 82(5):1000-7. PubMed ID: 20107208
[TBL] [Abstract][Full Text] [Related]
30. S-(1,2-dichlorovinyl)-L-cysteine-induced dedifferentiation and p53 gene mutations in LLC-PK1 cells: a comparative investigation with S-(2-chloroethyl)cysteine, potassium bromate, cis-platinum and styrene oxide.
Richter H; Vamvakas S
Toxicol Lett; 1998 Jan; 94(2):145-57. PubMed ID: 9574811
[TBL] [Abstract][Full Text] [Related]
31. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
Kiehlbauch CC; Kosanke SD; Ringer DP
Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
[TBL] [Abstract][Full Text] [Related]
32. Functional aspects of mono- and poly(ADP-ribosyl)ation: subcellular distribution and ADP-ribosyl turnover under conditions of repair and 'starvation'.
Hilz H; Wielckens K; Adamietz P; Bredehorst R; Kreymeier A
Princess Takamatsu Symp; 1983; 13():155-63. PubMed ID: 6654828
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribosyl)ation, genomic instability, and longevity.
Bürkle A
Ann N Y Acad Sci; 2000 Jun; 908():126-32. PubMed ID: 10911953
[TBL] [Abstract][Full Text] [Related]
34. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity.
Kunzmann A; Dedoussis G; Jajte J; Malavolta M; Mocchegiani E; Bürkle A
Exp Gerontol; 2008 May; 43(5):409-14. PubMed ID: 18022337
[TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.
Simbulan-Rosenthal CM; Rosenthal DS; Luo RB; Samara R; Jung M; Dritschilo A; Spoonde A; Smulson ME
Neoplasia; 2001; 3(3):179-88. PubMed ID: 11494111
[TBL] [Abstract][Full Text] [Related]
36. Photoactivated multivitamin preparation induces poly(ADP-ribosyl)ation, a DNA damage response in mammalian cells.
Zaniolo K; St-Laurent JF; Gagnon SN; Lavoie JC; Desnoyers S
Free Radic Biol Med; 2010 Apr; 48(8):1002-12. PubMed ID: 20100566
[TBL] [Abstract][Full Text] [Related]
37. Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.
Alemasova EE; Pestryakov PE; Sukhanova MV; Kretov DA; Moor NA; Curmi PA; Ovchinnikov LP; Lavrik OI
Biochimie; 2015 Dec; 119():36-44. PubMed ID: 26453809
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation.
Maltseva EA; Rechkunova NI; Sukhanova MV; Lavrik OI
J Biol Chem; 2015 Sep; 290(36):21811-20. PubMed ID: 26170451
[TBL] [Abstract][Full Text] [Related]
39. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
Davidovic L; Vodenicharov M; Affar EB; Poirier GG
Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
[TBL] [Abstract][Full Text] [Related]
40. Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure.
Komissarova EV; Rossman TG
Toxicol Appl Pharmacol; 2010 Mar; 243(3):399-404. PubMed ID: 20036271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
